EORTC/LinkedIn
Jul 2, 2025, 03:59
How widely is PET imaging used in brain tumour care across Europe? – EORTC
European Organisation for Research and Treatment of Cancer (EORTC) shared a post on LinkedIn:
“How widely is PET imaging used in brain tumour care across Europe?
A new survey by the EORTC Brain Tumour Group reveals that 93% of centres have access to PET, and 72% actively use it in clinical management, highlighting strong infrastructure for PET-based endpoints in future neuro-oncology trials.
The study, published in European Journal of Nuclear Medicine and Molecular Imaging, was lead by Maximilian Mair and Nathalie Albert and was conducted on behalf of the Nuclear Medicine Committee and the Quality Assurance Committee of the EORTC Brain Tumour Group.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 28, 2025, 11:32
Jul 28, 2025, 11:00
Jul 28, 2025, 10:53
Jul 28, 2025, 10:00
Jul 28, 2025, 09:59
Jul 28, 2025, 09:49